White David 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Mar 4, 2019
Insider Transaction Report
Form 4
White David
See Remarks
Transactions
- Award
Common Stock
2019-02-28+15,000→ 15,000 total - Award
Employee Stock Option (right to buy)
2019-02-28+30,000→ 30,000 totalExercise: $11.58Exp: 2029-02-27→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 28, 2020, 2021 and 2022, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]One fourth (1/4) of the shares underlying this option will vest on February 28, 2020, and the remainder of the shares underlying this option will vest at a rate of one forty-eighth (1/48) per month thereafter, provided the reporting person provides services to the Company through each such date.